Cardiovascular Diabetology
APRIL 4, 2024
Diabetes is a predominant driver of coronary artery disease worldwide. This study aims to unravel the distinct characteristics of oral and gut microbiota in diabetic coronary heart disease (DCHD). Simultaneous.
Medical Xpress - Cardiology
APRIL 4, 2024
Diabetes is a global health burden. A whopping 536 million people worldwide struggle with diabetes. Diabetic cardiomyopathy (DC) is a serious condition characterized by impaired heart function due to diabetes-related metabolic abnormalities.
DAIC
APRIL 4, 2024
milla1cf Thu, 04/04/2024 - 12:14 April 4, 2024 — Osso VR , a leader in immersive procedural training, announces the release of a co-developed curriculum with the American College of Cardiology ( ACC ). This collaboration expands Osso VR’s presence in the cardiovascular sector. With the integration of Osso VR's immersive technology and the expertise of the ACC, interventionalists will gain access to a state-of-the-art training simulation of the workflow and skills required to successfully perf
Cardiovascular Diabetology
APRIL 4, 2024
This study investigates the relationship between triglyceride-glucose (TyG) index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF).
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
DAIC
APRIL 4, 2024
Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health Cardiologists Achieve Historic First with Transcarotid TAVR in Southeast Houston 2. FDA Announces Abiomed Recall of the Instructions for Use for the Impella Left Sided Blood Pumps due to Perforation Risks 3. Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon 4.
Frontiers in Cardiovascular Medicine
APRIL 4, 2024
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major risk factor for cardiovascular diseases and chronic kidney disease. Research has shown that nitric oxide (NO) is a vasodilator that regulates vascular tension and the decrease of NO bioactivity is considered one of the potential pathogenesis of essential hypertension.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
APRIL 4, 2024
milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care. Three studies, presented at the American College of Cardiology ’s ( ACC ) Annual Scientific Session & Expo 2024 , have shown positive outcomes with real-world impact of Viz.ai in clinical practice for patients with hypertrophic cardiomyopathy (HCM), a commonly inherited heart disease that o
Medical Xpress - Cardiology
APRIL 4, 2024
A new study has found that increased coronary vessel wall thickness is significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV. The study is published in Radiology: Cardiothoracic Imaging.
NEJM Journal Watch - Cardiology
APRIL 4, 2024
A single chest x-ray predicted 10-year major adverse cardiac events as effectively as a traditional risk-prediction score.
HCPLive
APRIL 4, 2024
The first guideline for the management of osteoporosis in men provides recommendations for diagnosis, monitoring, and treatment.
Science Daily - Heart Disease
APRIL 4, 2024
Research into the protective effects of two anti-inflammatory molecules, transforming growth factor-beta1 (TGF 1) and Heligmosomoides polygyrus TGM (HpTGM), following heart attack found that both proteins reduced the inflammatory response within the injured heart and reduced mature scarring. Anti-inflammatory therapy to treat patients following acute myocardial infarction is an exciting prospect that deserves further translational studies, report investigators.
DAIC
APRIL 4, 2024
milla1cf Thu, 04/04/2024 - 10:09 April 4, 2024 — The U.S. Food and Drug Administration ( FDA ) announced that Medos International Sàrl is recalling Cerenovus CEREBASE DA Guide Sheath due to a crack found in the far end of the catheter, where different parts of the catheter are joined together. The FDA has identified this as a Class I recall , the most serious type of recall.
HCPLive
APRIL 4, 2024
Results suggest low-dose corticosteroids in combination with leflunomide are more efficacious for improving urine protein excretion with better safety than full-dose corticosteroids.
American College of Cardiology
APRIL 4, 2024
How does efficacy of dapagliflozin correlate with recency of heart failure hospitalization (HFH) across the range of left ventricular ejection fraction (LVEF)?
Med Page Today
APRIL 4, 2024
(MedPage Today) -- Note that some links may require registration or subscription. The world's oldest man died at the age of 114 in Venezuela, the Guinness World Records announced. He would have turned 115 next month. "We beat Big Pharma," said.
Medical Xpress - Cardiology
APRIL 4, 2024
Patients who have had surgery to create a Fontan circulation show changes in their genetic code, which may provide a new treatment opportunity to reduce premature aging.
American College of Cardiology
APRIL 4, 2024
At the American Heart Association's (AHA) Scientific Sessions 2023, the Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) trial was presented demonstrating that 2.4mg once weekly subcutaneous semaglutide.
Medical Xpress - Cardiology
APRIL 4, 2024
The model blood vessel was made using 3D bioprinting to help investigate how weightlessness changes the cardiovascular systems of astronauts in orbit.
American College of Cardiology
APRIL 4, 2024
During ACC.24 in Atlanta, GA, researchers will be presenting the latest studies on a wide variety of topics, including the cardiovascular effects of e-cigarette use, fortified egg consumption, greenspace environments and more. Here’s a brief overview of the consumer research highlights.
CardiacWire
APRIL 4, 2024
Verve Therapeutics’ stock price and gene editing momentum both took major dips last week, after the company announced that it paused its Heart-1 trial evaluating its VERVE-101 PCSK9 gene therapy, and revealed that it will now prioritize the development of its VERVE-102 therapy. Verve is developing investigational CRISPR-based gene editing therapies intended to allow long-term LDL-C reductions by permanently altering the PCSK9 gene.
American College of Cardiology
APRIL 4, 2024
What are the outcomes with transfemoral transcatheter aortic valve implantation (TAVI) in patients with pure aortic regurgitation (AR) using the Trilogy transcatheter heart valve?
HCPLive
APRIL 4, 2024
Patients with higher disease activity reported the highest perceived consequence of disease.
American College of Cardiology
APRIL 4, 2024
How safe and effective is the novel transcatheter electrosurgical procedure SESAME (SEptal Scoring Along Midline Endocardium) to reduce left ventricular outflow tract (LVOT) obstruction?
HCPLive
APRIL 4, 2024
Clinicians advocate for an at-parity approach to biosimilars, in which they, their patients, and the local market would have the freedom to choose the product that best suits their needs.
American College of Cardiology
APRIL 4, 2024
What are the short-term outcomes for patients with native or surgically repaired right ventricular outflow tract (RVOT) undergoing transcatheter pulmonary valve replacement (TPVR) with a self-expanding valve?
HCPLive
APRIL 4, 2024
Each month, our editorial staff compiles a recap of the top news in ophthalmology. Our March 2024 ophthalmology month in review features a recap of the latest news from the ophthalmic pipeline.
American College of Cardiology
APRIL 4, 2024
Can clinical outcomes be accurately predicted for patients with heart failure and preserved ejection fraction (HFpEF) using routinely collected variables?
HCPLive
APRIL 4, 2024
This analysis was conducted to evaluate the burden and disease characteristics of all 3 types of HAE among a set of Canadian patients.
American College of Cardiology
APRIL 4, 2024
The U.S. Food and Drug Administration (FDA) has announced that Abiomed is recalling the instructions for use for its Impella Left Sided Blood Pumps due to risk that the pump catheter may perforate the wall of the left ventricle in the heart.
HCPLive
APRIL 4, 2024
The FDA announcement on bimekizumab’s supplemental Biologics License Application followed the phase 3 BE HEARD I and II studies’ conclusion.
American College of Cardiology
APRIL 4, 2024
Infection from cardiac implantable devices (CIEDs) is a serious complication, and addressing discrepancies such as guideline education and streamlining care or referral pathways are key to bridging the gaps and improving patient outcomes, according to results from the COGNITO survey published Feb. 3 in JACC: Advances.
HCPLive
APRIL 4, 2024
Talal discusses the integration of a facilitated telemedicine approach into opioid treatment centers in New York, giving people with opioid use disorder easier access to HCV treatment.
American College of Cardiology
APRIL 4, 2024
Increasing diversity in clinical trial enrollment may impact who receives early application of recently approved innovations, based on findings from a study conducted on behalf of the Heart Failure Collaboratory and being presented at ACC.24 in Atlanta, GA.
Cardiovascular Diabetology
APRIL 4, 2024
Histone modifications play a critical role in chromatin remodelling and regulate gene expression in health and disease. Histone methyltransferases EZH1, EZH2, and demethylases UTX, JMJD3, and UTY catalyse trim.
Journal of Cardiothoracic Surgery
APRIL 4, 2024
Cardiopulmonary bypass induces a systemic inflammatory response and alterations in fluid homeostasis, resulting in generalized tissue edema. Additionally, ischemia-reperfusion injury following cardioplegic arr.
DAIC
APRIL 4, 2024
Viz.ai will be announced new clinical data supporting advancements in cardiology care during the American College of Cardiology Scientific Sessions, ACC.24. Image courtesy: VizAI milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care.
Expert insights. Personalized for you.
116 
Let's personalize your content